Whalegun
Home

Akebia Therapeutics AKBA spent $310K on lobbying in Q1 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$310,000
Quarter
Q1 2023
Stock
Akebia Therapeutics AKBA
Client
Akebia Therapeutics
Reported
23/04/20

Up 0.0% from last quarter

What else happened in Akebia Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Akebia Therapeutics's other lobbying reports

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $360K

    Reported 07/20

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $60K

    Reported 07/20

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $60K

    Reported 07/13

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $480K

    Reported 04/20

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $60K

    Reported 04/20

Akebia Therapeutics AKBA spent $310K on lobbying in Q1 2023 · Health Issues, Medicare | Whalegun